A real-world observational study of dupilumab treatment in adult patients with prurigo nodularis
Anais Brasileiros de Dermatologia · 2023
DOI: 10.1016/j.abd.2022.09.008 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Anais Brasileiros de Dermatologia, 2023. Verfasst von Zhixin Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Peking University First Hospital, Beijing Key Laboratory of Molecular Diagnosis on Dermatoses, National Clinical Research …. Hauptthemen laut MEDLINE: Prurigo, Neurodermatitis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Peking University First Hospital, Beijing Key Laboratory of Molecular Diagnosis on Dermatoses, National Clinical Research Center for Skin and Immune Disease, NMPA Key Laboratory for Quality Co…
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhang, Z., Li, S., Wang, Y., & Zhao, J. (2023). A real-world observational study of dupilumab treatment in adult patients with prurigo nodularis. Anais Brasileiros de Dermatologia. https://doi.org/10.1016/j.abd.2022.09.008
Vancouver
Zhang Z, Li S, Wang Y, Zhao J. A real-world observational study of dupilumab treatment in adult patients with prurigo nodularis. Anais Brasileiros de Dermatologia. 2023. doi:10.1016/j.abd.2022.09.008
BibTeX
@article{Zhang2023,
author = {Zhang, Zhixin and Li, Siyuan and Wang, Yang and Zhao, Jiahui},
title = {A real-world observational study of dupilumab treatment in adult patients with prurigo nodularis},
journal = {Anais Brasileiros de Dermatologia},
year = {2023},
doi = {10.1016/j.abd.2022.09.008}
}
EUVIMED